Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLHL20 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | SLX4IP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | GIMAP6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | SLC25A40 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | STX11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | EFNB3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | AC138645.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | USP42 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | DRAP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | NMNAT3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |